Clinical Trial Update: A Study to Investigate the Effect of HMB on Skeletal Muscle Wasting in Early Critical Illness [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the effect of HMB on skeletal muscle wasting in early critical illness is listed with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Drugs mentioned

• HMB (beta-hydroxy beta-methylbutyrate)

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Critical Illness | Phase 2 | Status: UNKNOWN